Related references
Note: Only part of the references are listed.1 alpha,25-Dihydroxyvitamin D-3 Inhibits C4-2 Prostate Cancer Cell Growth via a Retinoblastoma Protein (Rb)-Independent G(1) Arrest
Michele N. Washington et al.
PROSTATE (2011)
Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity
Jongchan Kim et al.
BMC CANCER (2010)
Inactivation of PI3K/AKT signaling inhibits glioma cell growth through modulation of β-catenin-mediated transcription
Lei Han et al.
BRAIN RESEARCH (2010)
Thiazolidinediones regulate expression of cell cycle proteins in human prostate cancer cells via PPARγ-dependent and PPARγ-independent pathways
Besstina E. Lyles et al.
CELL CYCLE (2009)
Myc down-regulation affects cyclin D1/cdk4 activity and induces apoptosis via Smac/Diablo pathway in an astrocytoma cell line
D. Amendola et al.
CELL PROLIFERATION (2009)
1α,25-Dihydroxyvitamin D3 Reduces c-Myc Expression, Inhibiting Proliferation and Causing G1 Accumulation in C4-2 Prostate Cancer Cells
JoyAnn N. Phillips Rohan et al.
ENDOCRINOLOGY (2009)
Loss of XIAP sensitizes colon cancer cells to PPARγ independent antitumor effects of troglitazone and 15-PGJ2
Liang Qiao et al.
CANCER LETTERS (2008)
Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-κB, and glucose regulation
Svetlana Kotliarova et al.
CANCER RESEARCH (2008)
Repeated electroconvulsive seizure induces c-Myc down-regulation and Bad inactivation in the rat frontal cortex
Won Je Jeon et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2008)
A novel mechanism by which thiazolidinediones facilitate the proteasomal degradation of cyclin D1 in cancer cells
Shuo Wei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Nuclear receptor hepatocyte nuclear factor 4 alpha 1 competes with oncoprotein c-Myc for control of the p21/WAF1 promoter
Wendy W. Hwang-Verslues et al.
MOLECULAR ENDOCRINOLOGY (2008)
Rosiglitazone attenuates insulin-like growth factor 1 receptor survival signaling in PC-3 cells
Efstathia Papageorgiou et al.
MOLECULAR MEDICINE (2008)
Activation of PI3K/Akt and MAPK pathways regulates Myc-mediated transcription by phosphorylating and promoting the degradation of Mad1
Jidong Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Effect of troglitazone on CYP1A1 induction
Hyung Gyun Kim et al.
TOXICOLOGY (2008)
Peroxisome proliferator-activated receptor-γ and growth inhibition by its ligands in prostate cancer
Daisuke Nagata et al.
Cancer Detection and Prevention (2008)
Sensing and Integration of Erk and PI3K Signals by Myc
Tae Lee et al.
PLOS COMPUTATIONAL BIOLOGY (2008)
gamma-Tocotrienol-induced apoptosis in human gastric cancer SGC-7901 cells is associated with a suppression in mitogen-activated protein kinase signalling
Wenguang Sun et al.
BRITISH JOURNAL OF NUTRITION (2008)
Myc down-regulation as a mechanism to activate the Rb pathway in STAT5A-induced senescence
Frederick A. Mallette et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Inhibition of cell motility by troglitazone in human ovarian carcinoma cell line
Yuh-Cheng Yang et al.
BMC CANCER (2007)
c-Myc is essential for hematopoietic stem cell differentiation and regulates Lin-Sca-1+c-Kit- cell generation through p21
Esther Baena et al.
EXPERIMENTAL HEMATOLOGY (2007)
Thiazolidinediones modulate the expression of β-catenin and other cell-cycle regulatory proteins by targeting the F-Box proteins of Skp1-Cul1-F-box protein E3 ubiquitin ligase independently of peroxisome proliferator-activated receptor γ
Shuo Wei et al.
MOLECULAR PHARMACOLOGY (2007)
Does the inhibition of c-myc expression mediate the anti-tumor activity of PPAR's ligands in prostate cancer cell lines?
Plotr Laidler et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2007)
The peroxisome proliferator-activated receptor-γ agonist troglitazone inhibits transforming growth factor-β-mediated glioma cell migration and brain invasion
Roland Coras et al.
MOLECULAR CANCER THERAPEUTICS (2007)
4-Hydroxynonenal and PPARγ ligands affect proliferation, differentiation, and apoptosis in colon cancer cells
Angelo Cerbone et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells
Takayuki Ikezoe et al.
LEUKEMIA RESEARCH (2007)
Peroxisome proliferator-activated receptor γ-independent suppression of androgen receptor expression by troglitazone mechanism and pharmacologic exploitation
Chih-Cheng Yang et al.
CANCER RESEARCH (2007)
γ-tocotrienol inhibits nuclear factor-κB signaling pathway through inhibition of receptor-interacting protein and TAK1 leading to suppression of antiapoptotic gene products and Potentiation of apoptosis
Kwang Seok Ahn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Effect of ligand troglitazone on peroxisome proliferator-activated receptor γ expression and cellular growth in human colon cancer cells
Mei Ming et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Peroxisome proliferator-activated receptor γ regulates E-cadherin expression and inhibits growth and invasion of prostate cancer
Jean-Sebastien Annicotte et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Role of post-translational modifications in regulating c-Myc proteolysis, transcriptional activity and biological function
Stephen R. Hann
SEMINARS IN CANCER BIOLOGY (2006)
Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway
Ziqiu Wang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Dramatic synergistic anticancer effect of clinically achievable doses of lovastatin and troglitazone
CJ Yao et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
RRR-α-Tocopherol succinate down-regulates oncogenic Ras signaling
S Donapaty et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Troglitazone inhibits cell growth and induces apoptosis of B-cell acute lymphoblastic leukemia cells with t(14;18)
M. Takenokuchi et al.
ACTA HAEMATOLOGICA (2006)
c-Myc suppresses p21WAF1/CIP1 expression during estrogen signaling and antiestrogen resistance in human breast cancer cells
S Mukherjee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Peroxisome proliferator-activated receptor γ activation modulates cyclin D1 transcription via β-catenin-independent and cAMP-response element-binding protein-dependent pathways in mouse hepatocytes
C Sharma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The life cycle of C-myc - From synthesis to degradation
RC Sears
CELL CYCLE (2004)
Ciglitizone and 15d PGJ2 induce apoptosis in Jurkat and Raji cells
CC Kanunfre et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2004)
Lack of cyclin-dependent kinase 4 inhibits c-myc tumorigenic activities in epithelial tissues
PLM de Marval et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Rosiglitazone versus placebo for men with prostate carcinoma and a rising serum prostate-specific antigen level after radical prostatectomy and/or radiation therapy
MR Smith et al.
CANCER (2004)
Phosphorylation by glycogen synthase kinase-3 controls c-Myc proteolysis and subnuclear localization
MA Gregory et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Gamma (γ) tocopherol upregulates peroxisome proliferator activated receptor (PPAR) gamma (γ) expression in SW 480 human colon cancer cell lines -: art. no. 25
SE Campbell et al.
BMC CANCER (2003)
Primary culture model of peroxisome proliferator-activated receptor γ activity in prostate cancer cells
Y Xu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2003)
Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cells
S Laurora et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Unsaturated fatty acids bind Myc-Max transcription factor and inhibit Myc-Max-DNA complex formation
S Chung et al.
CANCER LETTERS (2002)
Ligand activation of peroxisome proliferator-activated receptor γ induces apoptosis of leukemia cells by down-regulating the c-myc gene expression via blockade of the Tcf-4 activity
N Yamakawa-Karakida et al.
CELL DEATH AND DIFFERENTIATION (2002)
Effects of ligand activation of peroxisome proliferator-activated receptor γ in human prostate cancer
E Mueller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
